Suppr超能文献

心力衰竭的综合综述:剖析病因,解码病理生理机制,探索诊断方法,探讨药物干预,倡导生活方式改变,并在慢性心脏功能障碍的复杂领域中描绘新兴疗法的前景。

A comprehensive review of heart failure: Unraveling the etiology, decoding pathophysiological mechanisms, navigating diagnostic modalities, exploring pharmacological interventions, advocating lifestyle modifications, and charting the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction.

机构信息

University of California, Santa Cruz, CA.

Igbinedion University, Okada, Nigeria.

出版信息

Medicine (Baltimore). 2024 Jan 19;103(3):e36895. doi: 10.1097/MD.0000000000036895.

Abstract

Heart failure (HF) poses a significant global health burden, necessitating a profound understanding of its multifaceted dimensions. This comprehensive review aims to unravel the etiology, decode pathophysiological mechanisms, navigate diagnostic modalities, explore pharmacological interventions, advocate lifestyle modifications, and chart the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction. The exploration of HF begins with an insightful journey into its diverse etiological factors, encompassing genetic predispositions, hypertension, and coronary artery disease. Delving into pathophysiological mechanisms, this review elucidates the intricate processes of cardiac remodeling, neurohormonal activation, and cellular dysfunction that underlie the progression of HF. Diagnostic modalities play a pivotal role in unraveling the mysteries of HF by examining advanced imaging techniques, biomarkers, and comprehensive clinical assessments. The pharmacological interventions section provides an in-depth analysis of traditional medications, such as diuretics and angiotensin-converting enzyme inhibitors, while highlighting the emergence of novel drug classes transforming HF management. Advocating lifestyle modifications emphasizes the crucial role of diet, exercise, smoking cessation, and alcohol moderation in enhancing patient outcomes. Lastly, the review delves into the promising horizon of emerging therapies, offering a glimpse into current research, innovative treatment approaches, and potential breakthroughs. As HF management faces challenges in patient compliance, healthcare access, and education, this comprehensive review aims to equip healthcare professionals and researchers with a holistic understanding of chronic cardiac dysfunction's intricacies. In conclusion, synthesizing key findings emphasizes the need for an integrated and multidimensional approach to effectively address the complex landscape of heart failure.

摘要

心力衰竭(HF)是一个重大的全球健康负担,需要深入了解其多方面的维度。本综述旨在阐明病因学,解码病理生理机制,探索诊断方法,研究药物干预措施,倡导生活方式的改变,并探讨慢性心功能障碍复杂领域中新兴治疗方法的前景。HF 的探索始于深入了解其多种病因,包括遗传易感性、高血压和冠状动脉疾病。本综述深入探讨病理生理机制,阐明了心力衰竭进展所涉及的心脏重构、神经激素激活和细胞功能障碍的复杂过程。诊断方法通过检查先进的成像技术、生物标志物和全面的临床评估,在揭示 HF 的奥秘方面发挥着关键作用。药物干预部分对传统药物(如利尿剂和血管紧张素转换酶抑制剂)进行了深入分析,同时强调了改变 HF 管理的新型药物类别的出现。倡导生活方式的改变强调了饮食、运动、戒烟和限制饮酒在改善患者预后方面的重要作用。最后,综述深入探讨了新兴治疗方法的广阔前景,展示了当前的研究、创新的治疗方法和潜在的突破。由于 HF 管理在患者依从性、医疗保健可及性和教育方面面临挑战,本综述旨在为医疗保健专业人员和研究人员提供对慢性心功能障碍复杂性的全面理解。总之,综合关键发现强调需要采取综合和多维的方法来有效应对心力衰竭的复杂局面。

相似文献

2
Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies.
Cureus. 2023 Oct 4;15(10):e46486. doi: 10.7759/cureus.46486. eCollection 2023 Oct.
3
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.
4
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease.
Curr Cardiol Rev. 2024;20(4):e160424228949. doi: 10.2174/011573403X299265240405080030.
5
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.
Eur Heart J. 2014 Oct 21;35(40):2797-815. doi: 10.1093/eurheartj/ehu204. Epub 2014 Aug 7.
7
Heart failure: epidemiologic update.
Crit Care Nurs Q. 2009 Jan-Mar;32(1):24-32. doi: 10.1097/01.CNQ.0000343131.27318.36.
8
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure.
Biomolecules. 2024 Mar 6;14(3):309. doi: 10.3390/biom14030309.
9
Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
JAMA Cardiol. 2020 Mar 1;5(3):292-299. doi: 10.1001/jamacardio.2019.4987.

本文引用的文献

1
Heart failure and diabetes: Understanding the bidirectional relationship.
Medicine (Baltimore). 2023 Sep 15;102(37):e34906. doi: 10.1097/MD.0000000000034906.
2
Pathophysiology of heart failure.
Cardiovasc Diagn Ther. 2021 Feb;11(1):263-276. doi: 10.21037/cdt-20-302.
3
5
Heart failure after treatment for breast cancer.
Eur J Heart Fail. 2020 Feb;22(2):366-374. doi: 10.1002/ejhf.1620. Epub 2019 Nov 12.
7
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
8
A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans.
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719840192. doi: 10.1177/1753944719840192.
9
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.
Diabetologia. 2018 Oct;61(10):2108-2117. doi: 10.1007/s00125-018-4670-7. Epub 2018 Aug 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验